Zobrazeno 1 - 10
of 241
pro vyhledávání: '"Cartellieri, M."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Koristka, S., Ziller-Walter, P., Bergmann, R., Arndt, C., Feldmann, A., Kegler, A., Cartellieri, M., Ehninger, A., Ehninger, G., Bornhäuser, M., Bachmann, M.
Publikováno v:
Cancer Immunology, Immunotherapy (2019), 1401-1415
Although CAR T cell therapy has demonstrated tremendous clinical efficacy especially in hematological malignancies, severe treatment-associated toxicities still compromise the widespread application of this innovative technology. Therefore, developin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4577::b40cd2444002c5b4d53ecbd9f48f2a72
https://www.hzdr.de/publications/Publ-27834-1
https://www.hzdr.de/publications/Publ-27834-1
Autor:
Albert, S., Koristka, S., Gerbaulet, A., Cartellieri, M., Arndt, C., Feldmann, A., Berndt, N., Loureiro, L., Bonin, M., Ehninger, G., Eugster, A., Bonifacio, E., Bornhäuser, M., Bachmann, M., Ehninger, A.
Publikováno v:
Journal of Immunology 202(2019)6, 1735-1746
Long-term survival of adoptively transferred chimeric antigen receptor (CAR) T cells is often limited. Transplantation of hematopoietic stem cells (HSCs) transduced to express CARs could help to overcome this problem as CAR-armed HSCs can continuousl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4577::55153c71dba8b91925a3b70993715017
https://www.hzdr.de/publications/Publ-28607-1
https://www.hzdr.de/publications/Publ-28607-1
Autor:
Feldmann, A., Bergmann, R., Albert, S., Metwasi, N., Arndt, C., Aliperta, R., Koristka, S., Ehninger, A., Cartellieri, M., Ehninger, G., Steinbach, J., Bachmann, M.
Publikováno v:
Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, 06.-09.09.2017, Mainz, Deutschland
Recently, chimeric antigen receptor (CAR) expressing T cells have shown tremendous clinic effects in several cancer patients. However once those genetically modified T cells are adoptively transferred in a patient their reactivity cannot be controlle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::837919621433e91220694aff28ccd17e
https://www.hzdr.de/publications/Publ-26021-2
https://www.hzdr.de/publications/Publ-26021-2
Autor:
Bachmann, D., Aliperta, R., Bergmann, R., Feldmann, A., Koristka, S., Arndt, C., Loff, S., Welzel, P. B., Albert, S., Kegler, A., Ehninger, A., Cartellieri, M., Ehninger, G., Bornhäuser, M., Bonin, M., Werner, C., Pietzsch, J., Steinbach, J., Bachmann, M.
Publikováno v:
Oncotarget 9(2017), 7487-7500
Recent treatments of leukemias with T cells expressing chimeric antigen receptors (CARs) underline their impressive therapeutic potential but also their risk of severe side effects including cytokine release storms and tumor lysis syndrome. In case o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4577::584fdde730f5666d80dbe849332e5fb0
https://www.hzdr.de/publications/Publ-26281-1
https://www.hzdr.de/publications/Publ-26281-1
Autor:
Feldmann, A., Bergmann, R., Albert, S., Arndt, C., Aliperta, R., Koristka, S., Ehninger, A., Cartellieri, M., Ehninger, G., Steinbach, J., Bachmann, M.
Publikováno v:
Cellular Therapy 2017, 9th International Symposium Erlangen, 16.-17.03.2017, Erlangen, Deutschland
In recent years, adoptively transferred autologous human T cells that are genetically modified with chimeric antigen receptors (CARs) have been very successfully used for treatment of different hematological malignancies. However, immunotherapy of so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4577::cd9326cd848f08723d7af0b3896ff023
https://www.hzdr.de/publications/Publ-25247-1
https://www.hzdr.de/publications/Publ-25247-1
Autor:
Albert, S., Bergmann, R., Koristka, S., Feldmann, A., Arndt, C., Aliperta, R., Ehninger, A., Cartellieri, M., Ehninger, G., Steinbach, J., Bachmann, M.
Publikováno v:
47th Annual Meeting of the German Society for Immunology, 12.09.2017, Erlangen, Germany
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4577::69ce5a963c0e528844629da83b60b804
https://www.hzdr.de/publications/Publ-26056-1
https://www.hzdr.de/publications/Publ-26056-1
Autor:
Mitwasi, N., Feldmann, A., Bergmann, R., Berndt, N., Arndt, C., Koristka, S., Kegler, A., Jureczek, J., Hoffmann, A., Ehninger, A., Cartellieri, M., Albert, S., Rössig, C., Ehninger, G., Pietzsch, J., Steinbach, J., Bachmann, M.
Publikováno v:
Oncotarget 8(2017), 108584-108603
As the expression of a tumor associated antigen (TAA) is commonly not restricted to tumor cells adoptively transferred T cells modified to express a conventional chimeric antigen receptor (CAR) might not only destroy the tumor cells but also attack t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4577::6d03e6c7a9f46e5e04b067b756d40f5e
https://www.hzdr.de/publications/Publ-26018-1
https://www.hzdr.de/publications/Publ-26018-1
Autor:
Albert, S., Bergmann, R., Koristka, S., Feldmann, A., Arndt, C., Aliperta, R., Ehninger, A., Cartellieri, M., Ehninger, G., Steinbach, J., Bachmann, M.
Publikováno v:
Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, 06.09.2017, Mainz, Deutschland
In general, adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells has an impressive immunotherapeutic potential. However, due to the time-consuming establishment of new CAR constructs, the risk of life-threatening side effects, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4577::64e236f5ec3437c70201bf50d5584088
https://www.hzdr.de/publications/Publ-26020-1
https://www.hzdr.de/publications/Publ-26020-1